本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
滿地可2025年10月17日 /美通社/ -- 首次發表國際人工智能安全報告的重要更新，及時提供先進人工智能能力與風險的更新。 該報告由圖靈獎得主兼電腦科學家 Yoshua Bengio 主導，超過 100 位國際專家參與，並得到超過 30 個國家/地區和國際組織（包括歐盟、經濟合作暨發展組織和聯合國）的支持。 由於認識到該領域太迅速發展而單一年度報告無法涵蓋，因此引入重要更新，提供更簡短兼更集中的關鍵發展報告。這將確保政策制定者得到最新文獻合編，而告知證據為本的政策制定。 首次重要更新涵蓋能力進步與風險影響： 人工智能模型不斷改善解決複雜問題的能力：例如，多個領先系統現可於一組現實世界軟體工程問題中，完成超過 60% 任務。到了 2025 年初，它們僅可完成當中約 40% 問題，而到了 2024 年初，它們無法解決任何問題。（事實上，自從最終確定本更新的文字後，效能已提升至超過 70%。） 業界參與者已採取全新防範保障措施： 在無法明確排除最新模型可協助發展化學、生物、放射和核子風險的可能性後，大型人工智能開發商們便已主動推出具備額外安全措施的最新模型。 人工智能模型接受評估過程期間，越來越多表現策略行為，而導致監督挑戰：人工智能模型越來越可能顯示它們正在接受評估的意識，並相應地改變自身輸出。這對開發人員和測試人員於新人工智能模型部署前準確評估人工智能模型功能的能力，提出重大質疑。 該報告主席、滿地可大學教授、LawZero 科學主任兼 Mila - Quebec AI Institute 科學顧問 Yoshua Bengio 表示： 「自九個月前發表首份國際人工智能安全報告後， Yoshua Bengio能力持續快速兼持續地發展。我們必須繼續集體理解Yoshua Bengio的風險，以及安全措施。本重要更新提供及時兼證據為本的簡介，給全球決策者獲得最新科學資料，從而確保主動兼明智的管治。它也為將於 2026 年初在印度舉行 AI Impact Summit 發表綜合報告前，充當期待橋樑。 」 簡介 國際人工智能安全報告是先進人工智能系統能力與風險證據的合編。它旨在透過為決策者提供證據基礎，而支援全球明智政策制定。該報告由超過 100 名獨立專家組成的多元化團隊撰寫，並得到來自超過 30 個國家/地區和國際組織（包括歐盟、經濟合作暨發展組織和聯合國）提名代表所組成之專家顧問小組的支持。儘管該報告承認人工智能的龐大潛在優勢，但該報告重點是識別風險和評估緩解策略，從而確保安全地發展和使用人工智能 ，造福人群。該報告由英國政府委託，而秘書處設於 UK AI Security Institute。 聯絡方法：Mila Medias，medias@mila.quebec；DSIT 傳媒查詢，press@dsit.gov.uk
SAN JOSE, Calif., Oct. 17, 2025 /PRNewswire/ -- Global data centers are facing new challenges driven by AI – greater compute demand, larger working sets, and more stringent energy efficiency requirements. At this year's OCP Global Summit, Compal Electronics (Compal; Ticker: 2324.TW) presented a comprehensive vision for the data center of the future, delivering end-to-end solutions that cover compute, memory, and cooling. Compal Showcases Comprehensive Data Center Solutions at 2025 OCP Global Summit In terms of compute power, Compal is showcasing its latest AI server — SGX30-2 / 10U — based on the NVIDIA HGX B300 platform. The system is built on the NVIDIA Blackwell architecture, supports eight NVIDIA Blackwell Ultra GPUs connected with fifth-generation NVIDIA NVLink, and features dual Intel® Xeon® 6 processors, purpose-built for large-scale AI model training, inference, and HPC (high-performance computing) workloads. NVIDIA Blackwell Ultra GPUs are based on NVIDIA Blackwell architecture, provides up to 2.1 TB of HBM3e memory and 1.8 TB/s GPU-to-GPU NVLink bandwidth, for a total interconnect bandwidth of 14.4 TB/s, ensuring low-laten, high-speed access to massive working sets. It delivers 144 PFLOPS of FP4 inference performance and approximately 72 PFLOPS of FP8 performance, representing a 7x increase in compute performance compared to the previous NVIDIA Hopper generation. This design enables enterprises to perform high-throughput training and efficient inference on a single platform, significantly shortening AI model development and deployment cycles. The showcase also featured CXL (Compute Express Link) and RDMA (Remote Direct Memory Access) technologies for AI (Artificial Intelligence) Memory Expansion, addressing the growing memory bottlenecks in workloads such as large language model training and HPC. Through the CXL.mem protocol, servers can seamlessly access pooled SCM (Storage-Class Memory)-based Memory Expanders within a rack, enabling CPUs and GPUs to process larger datasets beyond HBM (High Bandwidth Memory) limits with cache-coherent efficiency. Within the evolving memory architecture, bridging GPU memory and storage a direct path through PCIe interface. It's intelligent DMA (Direct Memory Access) offload and low-latency data-path design transform conventional NVMe (Non-Volatile Memory Express) storage into a memory-like extension, realizing the Storage-as-Memory concept that enables high-speed data access without increasing CPU overhead. Extending beyond the rack, RDMA allows direct data movement across servers and data centers via InfiniBand or RoCE (RDMA over Converged Ethernet) networks, supporting large-scale memory disaggregation and resource pooling. Together, these technologies redefine how data flows across AI clusters, creating a unified, reconfigurable, and energy-efficient infrastructure that evolves from today's PCIe-based systems toward next-generation GPU direct storage and CXL-enabled architectures. With this comprehensive showcase, Compal demonstrates a clear, practical path from today's infrastructure to the data center of the future, and underscores its role as a true system integrator — not just a technology provider, but a long-term strategic partner for enterprises in their digital transformation journey," said Alan Chang, Vice President of the Infrastructure Solutions Business Group at Compal. About Compal Founded in 1984, Compal is a leading manufacturer in the notebook and smart device industry, creating brand value in collaboration with various sectors. Its groundbreaking product designs have received numerous international awards. In 2025, Compal was recognized by CommonWealth Magazine as one of Taiwan's top 7 manufacturers and has consistently ranked among the Forbes Global 2000 companies. In recent years, Compal has actively developed emerging businesses, including cloud servers, auto electronics, and smart medical, leveraging its integrated hardware and software R&D and manufacturing capabilities to create relevant solutions. More information, please visit https://www.compal.com Media Contact Jack Wang Vice president and Spokesperson +886-2-8797-8588 Investor@compal.com
NEWPORT BEACH, Calif., Oct. 16, 2025 /PRNewswire/ -- The California Institute of Artificial Intelligence (CIAI) announced the launch of The Dawn Directive, a pioneering educational initiative fully created by an Agentic AI system developed by MindHYVE.ai™. This groundbreaking curriculum marks a new epoch in the evolution of learning—where artificial intelligence doesn't just inform education but designs it. Delivered through the ArthurAI™ Virtual Learning Platform (VLP), The Dawn Directive is the world's first AI-generated program for comprehensive AI literacy, fluency, and ethics—engineered to prepare students, professionals, and educators to thrive in an intelligent, automated world. A Vision for an AI-Literate World CIAI's mission is rooted in a singular goal: to make AI literacy as universal and essential as computer literacy became in the 1990s. By closing the global AI fluency gap, the Institute aims to ensure that no individual, organization, or nation is left behind as AI becomes the defining force of modern progress. "The Dawn Directive is more than a curriculum—it's a declaration of intent," said a CIAI spokesperson."It represents a future where humans and AI co-create knowledge, ensuring education evolves at the same speed as innovation itself." About The Dawn Directive The Dawn Directive is an 18-course learning system organized across six major domains: AI Literacy – foundational understanding of AI, history, and concepts. AI Fluency – hands-on application in prompting, orchestration, and model interaction. AI Applications – real-world creation using no-code and agentic systems. AI + Ethics – critical awareness of fairness, bias, governance, and accountability. AI for Educators – integrating AI tools responsibly into pedagogy. AI Future-Skills – resilience, creativity, and meta-learning for the AGI era. Delivered via the ArthurAI™ Virtual Learning Platform, the Directive leverages adaptive learning, cognitive profiling, and neuro-symbolic reasoning to deliver personalized, explainable education at scale. Each learner receives dynamic AI-driven tutoring, adaptive course content, and ethical feedback systems—creating a fully autonomous, yet deeply human-centered learning experience. Impact: Redefining Workforce and Educational Readiness The Dawn Directive enables governments, institutions, and enterprises to rapidly upskill workforces for the AI economy by providing: Scalable AI literacy certification across professions and geographies. Workflow-embedded learning that mirrors real-world AI collaboration. Ethical readiness to align with upcoming AI governance and compliance frameworks. Continuous learning ecosystems that evolve in real time as AI technologies advance. CIAI's learning pathways—AI-Ready Professional, AI Collaborator, and AI Leader—set a global benchmark for competence in responsible AI use, communication, and leadership. The Significance of an AI-Created Curriculum "For the first time, AI is both the subject and the author of education," said Bill Faruki, CEO & Founder of MindHYVE. "The Dawn Directive demonstrates what happens when intelligent systems collaborate with human purpose—creating a learning standard that evolves as fast as the world does." This initiative redefines the relationship between human educators and machine intelligence—establishing a living curriculum that learns, adapts, and scales globally. About MindHYVE.ai™ MindHYVE.ai™ is redefining the boundaries of intelligence by engineering autonomous systems and deploying domain-specific AGI agents across real-world sectors. Powered by the Ava-Fusion™ large reasoning model and architected for agent coordination, swarm intelligence, and adaptive autonomy, MindHYVE's technology stack is revolutionizing law, medicine, finance, education, and governance. With operations in North America, Asia, and in Africa, MindHYVE.ai™ is on a mission to democratize access to transformative intelligence and architect the infrastructure for post-scarcity economies. Backed by HYVE Labs, the company continues to shape the future of agentic systems on a global scale. About CIAI The California Institute of Artificial Intelligence (CIAI, LLC) is an educational organization based in Newport Beach, California. CIAI specializes in accessible, ethical, and industry-specific AI learning, offering online certification through its ArthurAI™ platform. Its mission is to equip learners, educators, and organizations with practical fluency, data literacy, and responsible AI capabilities to succeed in a rapidly evolving digital world. Website : www.ciai.com | Email : hello@ciai.com | Contact : +1 (949) 200-8668 Media Contact:Marc OrtizEmail: hello@ciai.com THE DAWN DIRECTIVE: World’s First AI-Created Curriculum for Global AI Fluency
In the news release, SHOPLINE Secures In-Principle Approval for Major Payment Institution License from the Monetary Authority of Singapore, issued 15-Oct-2025 by SHOPLINE over PR Newswire, we are advised by the company that the headline has changed, the first four paragraphs have been changed and are now three paragraphs, and the first paragraph below the bullets now reads "The MPI license, if granted, will enhance..." rather than "The MPI license will enhance..." as originally issued inadvertently. The complete, corrected release follows: SHOPLINE Subsidiary, Instage Technology Pte Ltd, Secures In-Principle Approval for MPI License from Monetary Authority of Singapore SINGAPORE, Oct. 16, 2025 /PRNewswire/ -- Instage Technology Pte Ltd, a subsidiary of SHOPLINE, the global commerce platform trusted by over 600,000 merchants, today announced that it has received In-Principle Approval ("IPA") from the Monetary Authority of Singapore ("MAS") for a Major Payment Institution ("MPI") license. The MPI license, if granted, will authorize SHOPLINE to provide five regulated payment services, including: Account Issuance Service, Domestic Money Transfer Service, Cross-Border Money Transfer Service, Merchant Acquisition Service, and E-Money Issuance Service. "The MPI license is a key milestone in our global strategy," said Raymond Hsu, Co-President of SHOPLINE. "It highlights our commitment to meeting the highest regulatory standards while delivering secure, efficient, and borderless payment experiences for merchants." Driving Merchant Growth Through Payments Innovation With the MPI license, SHOPLINE will be able to provide merchants with direct, end-to-end payment services—from KYC verification and transaction processing to fund settlement—without relying solely on third-party providers. The benefits include: More competitive pricing and faster settlements through reduced intermediaries Greater security and smoother experiences via end-to-end control Multi-currency capabilities that support cross-border growth Strengthening Regional and Global Presence The MPI license, if granted, will enhance SHOPLINE's commerce platform offerings, reinforcing its mission to provide merchants with a seamless ecosystem that integrates payments and e-commerce. This milestone builds upon SHOPLINE's existing regulatory presence in Asia, further deepening its footprint in Asia-Pacific. By harnessing Singapore's position as a global fintech hub, SHOPLINE is uniquely equipped to empower merchants with seamless end-to-end payment solutions—enabling them to build international connections, accelerate cross-border growth, and unlock new opportunities in the fast-evolving digital commerce landscape. About SHOPLINEFounded in 2013, SHOPLINE is a leading global commerce Software-as-a-Service (SaaS) provider, empowering brands and retailers to build, launch and scale their business around the world. SHOPLINE offers a fully integrated platform that provides merchants with solutions such as ecommerce, POS, social commerce, omni-channel marketing, B2B management, and more. Brands are also empowered to create custom integrations and unique shopping experiences with SHOPLINE's open platform architecture, comprehensive APIs, and extensive global partner network. SHOPLINE is headquartered in Singapore with over 2000 employees operating globally. Learn more at www.shopline.com. Follow us on LinkedIn. An in-principle approval (IPA) reflects MAS' view that a licence may be issued to the applicant upon the fulfilment of specified conditions and provided there are no material adverse developments affecting the applicant. An IPA does not constitute a licence for a Company to provide payment services at this juncture. MAS reserves the right to rescind the IPA in circumstances where it considers appropriate.
NEWPORT BEACH, Calif. and SWABI, Pakistan, Oct. 16, 2025 /PRNewswire/ -- In a transformative move that places Pakistan on the global map of AI-enabled education, MindHYVE.ai™, a U.S.-based pioneer in agentic artificial intelligence, and the Ghulam Ishaq Khan Institute of Engineering Sciences and Technology (GIKI), one of South Asia's most prestigious engineering universities, have entered into a strategic alliance to integrate AI-powered learning and institutional intelligence into academia. When a Nation’s Brightest Minds Meet the World’s Smartest Machines (GIKI and MindHYVE.ai™ unite to transform higher education) The partnership will deploy ArthurAI™, MindHYVE's flagship agentic learning system, across GIKI's academic environment — enabling personalized, data-driven learning experiences and AI-assisted teaching methodologies for thousands of students and faculty members. A Vision for the Future of Learning Artificial Intelligence is redefining education at unprecedented speed. According to UNESCO and the World Economic Forum: Over 85% of global institutions plan to integrate AI-driven learning systems by 2030. Two-thirds of future jobs will require AI literacy and digital fluency. By 2027, the AI-in-education market is expected to exceed USD 25 billion, driven by personalized learning platforms and intelligent tutoring systems. Through this alliance, GIKI and MindHYVE aim to position Pakistan among the global leaders in AI-integrated education — combining world-class pedagogy, research, and technology to prepare students for the next industrial era. The collaboration will: Empower students through adaptive learning pathways and real-time academic insights. Enable faculty to design, deliver, and analyze courses with AI-assisted precision. Establish GIKI as the first fully AI-enabled higher education institution in Pakistan. Introduce The Dawn Directive, a groundbreaking global AI fluency and ethics program authored by the California Institute of Artificial Intelligence (CIAI) and powered by MindHYVE's agentic ecosystem. Leadership Perspective Bill Faruki, Founder and CEO of MindHYVE, said:"This partnership is more than an agreement — it's a turning point. With GIKI, we are redefining what higher education looks like in the age of intelligence. The future of learning will not be passive; it will be dynamic, predictive, and profoundly human-centered." Dr. Fazal Khalid, Rector of GIKI, stated:"At GIKI, we have always led through innovation. By integrating MindHYVE's ArthurAI™ technology, we are not just embracing AI — we are reshaping the future of academic excellence in Pakistan and setting a new benchmark for intelligent education across the region." About MindHYVE.ai™ MindHYVE.ai™ is redefining the boundaries of intelligence by engineering autonomous systems and deploying domain-specific AGI agents across real-world sectors. Powered by the Ava-Fusion™ large reasoning model and architected for agent coordination, swarm intelligence, and adaptive autonomy, MindHYVE's technology stack is revolutionizing law, medicine, finance, education, and governance. With operations in North America, Asia, and in Africa, MindHYVE.ai™ is on a mission to democratize access to transformative intelligence and architect the infrastructure for post-scarcity economies. Backed by HYVE Labs, the company continues to shape the future of agentic systems on a global scale. Website: www.mindhyve.ai | Email: hello@mindhyve.io | Contact: +1 (949) 200-8668 Media Contact:Marc OrtizEmail: marc.ortiz@mindhyve.io
ROLLE, Switzerland and TOKYO, Oct. 16, 2025 /PRNewswire/ -- A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company pioneering data-driven medicine, today announced at ESMO a strategic agreement to bring cutting-edge liquid biopsy genomic testing to the Japanese population. The companies will also partner to commercialize a liquid biopsy companion diagnostic aimed at advancing personalized and precision cancer care in Japan. As a market leader for genetic testing in Japan with a high-throughput laboratory located in central Tokyo, A.D.A.M. Innovations has served the Japanese population for over 20 years and completed over 2.8 million genomic tests to-date. A.D.A.M. Innovations will continue its legacy of bringing global innovations to Japan by adopting the AI-powered SOPHiA DDM™ Platform to advance personalized cancer testing across the country. The partnership will initially focus on launching the liquid biopsy application, MSK-ACCESS® powered with SOPHiA DDMTM. This innovative liquid biopsy test is designed to detect actionable genomic alterations from a single blood draw, leveraging state-of-the-art AI to analyze circulating tumor DNA (ctDNA) in a minimally invasive manner. The test utilizes a matched tumor-normal approach which improves accuracy and avoids false positives. By launching the test locally and analyzing samples in-house, A.D.A.M. Innovations will expedite testing turnaround times, reduce costs to patients, and advance local cancer research. As part of the partnership, the companies also aim to develop a liquid biopsy companion diagnostic (CDx) test in Japan. By developing the application into a CDx, more patients can gain access to the benefits of the high-quality tumor profiling test, advancing personalized healthcare at scale. The offering will also provide pharmaceutical partners with a powerful new tool to accelerate drug development and market access in Japan. The companies will collaborate across all steps of the development process, with A.D.A.M. Innovations leveraging its deep clinical and regulatory expertise to support regulatory submissions in Japan. "Making precision oncology more accessible to patients in Japan is a significant milestone," said Ross Muken, President, SOPHiA GENETICS. "By combining A.D.A.M. Innovations' strong clinical expertise and local presence with the global reach of the SOPHiA DDM™ Platform, we can drive the nationwide adoption of data-driven medicine, advancing both clinical research and the delivery of personalized oncology care." "For over two decades, we have supported academic, research and medical institutions with advanced clinical genomic testing," commented Michel Mommejat, President of A.D.A.M. Innovations. "Through our partnership with SOPHiA GENETICS and its AI-driven platform, we are taking a major step forward in accelerating precision oncology across Japan. Testing locally enables faster turnaround times, reduces costs, enhances patient care, and supports global CDx deployments." The collaboration was formally announced from the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin. The announcement underscores both companies' shared commitment to advancing data-driven and liquid biopsy-based solutions for cancer care in Japan. Learn more by connecting with SOPHiA GENETICS and A.D.A.M. Innovations at ESMO booth #2039 from October 17-21, 2025. For more information on SOPHiA GENETICS, visit SOPHiAGENETICS.COM, or connect on LinkedIn. For more information on A.D.A.M. Innovations, visit ADAM-INNOVATIONS.COM or connect on LinkedIn. About SOPHiA GENETICS SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of the SOPHiA DDM™ Platform, which analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn. SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. The information in this press release is about products that may or may not be available in different countries and, if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact support@sophiagenetics.com to obtain the appropriate product information for your country of residence. SOPHiA GENETICS Forward-Looking Statements: This press release contains statements that constitute forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations and financial position, business strategy, products, and technology, as well as plans and objectives of management for future operations, are forward-looking statements. Forward-looking statements are based on our management's beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including those described in our filings with the U.S. Securities and Exchange Commission. No assurance can be given that such future results will be achieved. Such forward-looking statements contained in this press release speak only as of the date hereof. We expressly disclaim any obligation or undertaking to update these forward-looking statements contained in this press release to reflect any change in our expectations or any change in events, conditions, or circumstances on which such statements are based, unless required to do so by applicable law. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements. About A.D.A.M. Innovations Co. Founded in 2004 in Tokyo, A.D.A.M. Innovations (currently operating as Genesis Healthcare Co.) is a pioneer in genomics, AI, and precision health solutions. The company develops cutting-edge technologies spanning clinical diagnostics, consumer genetics, and AI-driven R&D data platforms. To date, it has conducted more than 2.8 million genetic tests and maintains the largest R&D genomic database of the Japanese population. The company's name will change to A.D.A.M. Innovations Co. effective November 1, 2025.
A12 藝術空間
D-Link
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
